Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Retained Earnings (2018 - 2025)

Inventiva (IVA) posted quarterly Retained Earnings of -$3.2 million for Q4 2025, down 174.58% year-over-year from $4.3 million in Q4 2024, and up 100.0% quarter-over-quarter from -$239.4 billion in Q2 2025.

Analysis

Inventiva (IVA) Retained Earnings (2018 - 2025) Analysis & Trends

Inventiva's Retained Earnings history runs 8 years deep, the most recent figure standing at -$3.2 million for Q4 2025.

  • In Q4 2025, Retained Earnings fell 174.58% year-over-year to -$3.2 million; the TTM figure through Dec 2025 stood at -$3.2 million (down 174.58% YoY), while the FY2025 annual figure was -$3.2 million, down 174.58% from the prior year.
  • Retained Earnings for Q4 2025 stood at -$3.2 million, up from -$239.4 billion in the prior quarter.
  • The five-year high for Retained Earnings was -$190842.4 in Q4 2023, with the low at -$239.4 billion in Q2 2025.
  • The 5-year median for Retained Earnings is -$18.7 million (2025), against an average of -$35.0 billion.
  • Peak annual rise in Retained Earnings reached 174.58% in 2025, while the deepest fall reached 21839761.57% in 2025.
  • Inventiva's Retained Earnings stood at -$30.7 billion in 2021, then slumped by 160.48% to -$79.9 billion in 2022, then surged by 100.0% to -$191517.3 in 2023, then tumbled by 507.62% to -$1.2 million in 2024, then sank by 174.58% to -$3.2 million in 2025.
  • Business Quant data shows IVA's Retained Earnings at -$3.2 million in Q4 2025, -$239.4 billion in Q2 2025, and -$1.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Inventiva 893.85 Mn 893.85 Mn - -412.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -412.23 Mn
Jun 30, 2025 -199.09 Mn
Dec 31, 2024 -196.85 Mn
Jun 30, 2024 -1.63 Mn
Dec 31, 2023 -118.81 Mn
Dec 31, 2022 -55.37 Mn
Jun 30, 2022 -31.44 Mn
Dec 31, 2021 -56.78 Mn
Jun 30, 2021 -27.86 Mn
Mar 31, 2021 -10.66 Mn
Dec 31, 2020 -40.08 Mn
Dec 31, 2019 -33.45 Mn
Dec 31, 2018 -37.68 Mn